A Novel IGLC2 Gene Linked With Prognosis of Triple-Negative Breast Cancer

Yu Tien Chang, Wen Chiuan Tsai, Wei Zhi Lin, Chia Chao Wu, Jyh Cherng Yu, Vincent S. Tseng, Guo Shiou Liao, Je Ming Hu, Huan Ming Hsu, Yu Jia Chang, Meng Chiung Lin, Chi Ming Chu, Chien Yi Yang

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Immunoglobulin-related genes are associated with the favorable prognosis of triple-negative breast cancer (TNBC) patients. We aimed to analyze the function and prognostic value of immunoglobulin lambda constant 2 (IGLC2) in TNBC patients. Methods: We knocked down the gene expression of IGLC2 (IGLC2-KD) in MDA-MB-231 cells to evaluate the proliferation, migration, and invasion of tumors via 3-(4,5-Dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, wound healing, and transwell cell migration assay respectively. Relapse-free survival (RFS) and distant metastasis-free survival (DMFS) analyses were conducted using the KM plotter online tool. The GSE76275 data set was used to analyze the association of IGLC2 and clinical characteristics. A pathway enrichment analysis was conducted using the next-generation sequencing data of wild-type and IGLC2-KD MDA-MB-231 cells. Results: The low gene expression of IGLC2 was related to unfavorable RFS, DMFS. The high expression of IGLC2 was exhibited in the basal-like immune-activated (BLIA) TNBC molecular subtype, which was immune-activated and showed excellent response to immune therapy. IGLC2 was positively correlated with programmed death-ligand 1 (PD-L1) as shown by Spearman correlation (r = 0.25, p < 0.0001). IGLC2 had a strong prognostic effect on lymph node-negative TNBC (RFS range: 0.31, q value= 8.2e-05; DMFS = 0.16, q value = 8.2e-05) but had no significance on lymph node-positive ones. The shRNA-mediated silencing of IGLC2 increased the proliferation, migration, and invasion of MDA-MB-231 cells. The results of pathway enrichment analysis showed that IGLC2 is related to the PI3K-Akt signaling pathway, MAPK signaling pathway, and extracellular matrix–receptor interaction. We confirmed that MDA-MB-231 tumor cells expressed IGLC2, subverting the traditional finding of generation by immune cells. Conclusions: IGLC2 linked with the proliferation, migration, and invasion of MDA-MB-231 cells. A high expression of IGLC2 was related to favorable prognosis for TNBC patients. IGLC2 may serve as a biomarker for the identification of TNBC patients who can benefit the most from immune checkpoint blockade treatment.

Original languageEnglish
Article number759952
JournalFrontiers in Oncology
Volume11
DOIs
Publication statusPublished - Jan 27 2022

Keywords

  • breast cancer
  • distant metastasis-free survival
  • immunoglobulin
  • MDA-MB-231
  • next-generation sequencing
  • prognosis
  • relapse-free survival
  • triple-negative breast cancer (TNBC)

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'A Novel IGLC2 Gene Linked With Prognosis of Triple-Negative Breast Cancer'. Together they form a unique fingerprint.

Cite this